Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Leander

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Mathematical Biosciences|March 18, 2014
Stochastic differential equations as a tool to regularize the parameter estimation problem for continuous time dynamical systems given discrete time measurementsJacob Leander, Torbjörn Lundh, Mats Jirstrand
Pharmacology Research & Perspectives|May 8, 2026
Population Pharmacokinetics of the Novel Myeloperoxidase Inhibitor MitiperstatMikael Sunnåker, Jacob Leander, Hans Ericsson
Clinical Pharmacokinetics|September 20, 2020
Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of BodyweightDinko Rekić, Susanne Johansson, Jacob Leander
Journal of Pharmacokinetics and Pharmacodynamics|March 25, 2015
Using sensitivity equations for computing gradients of the FOCE and FOCEI approximations to the population likelihoodJoachim Almquist, Jacob Leander, Mats Jirstrand
The AAPS Journal|August 3, 2018
Exact Gradients Improve Parameter Estimation in Nonlinear Mixed Effects Models with Stochastic DynamicsHelga Kristin Olafsdottir, Jacob Leander, Joachim Almquist, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2021
A stochastic mixed effects model to assess treatment effects and fluctuations in home-measured peak expiratory flow and the association with exacerbation risk in asthmaJacob Leander, Mats Jirstrand, Ulf G Eriksson, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 6, 2026
Modeling Peak Expiratory Flow in Patients With Asthma and Quantifying Treatment Effects Using a Mixed-Effects Hidden Markov ModelLudvig Jakobsson, Marcus Baaz, Jacob Leander, et al.
The AAPS Journal|February 20, 2015
Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker RatsJacob Leander, Joachim Almquist, Christine Ahlström, et al.
Statistics in Medicine|March 13, 2026
Location-Scale Latent Process Model for Repeated Ordinal Patient-Reported OutcomesAgnieszka Król, Robert Palmér, Jacob Leander, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 17, 2021
A semi-mechanistic exposure-response model to assess the effects of verinurad, a potent URAT1 inhibitor, on serum and urine uric acid in patients with hyperuricemia-associated diseasesJacob Leander, Mikael Sunnåker, Dinko Rekić, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Mathematical Biosciences|March 18, 2014
Stochastic differential equations as a tool to regularize the parameter estimation problem for continuous time dynamical systems given discrete time measurementsJacob Leander, Torbjörn Lundh, Mats Jirstrand
Pharmacology Research & Perspectives|May 8, 2026
Population Pharmacokinetics of the Novel Myeloperoxidase Inhibitor MitiperstatMikael Sunnåker, Jacob Leander, Hans Ericsson
Clinical Pharmacokinetics|September 20, 2020
Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of BodyweightDinko Rekić, Susanne Johansson, Jacob Leander
Journal of Pharmacokinetics and Pharmacodynamics|March 25, 2015
Using sensitivity equations for computing gradients of the FOCE and FOCEI approximations to the population likelihoodJoachim Almquist, Jacob Leander, Mats Jirstrand
The AAPS Journal|August 3, 2018
Exact Gradients Improve Parameter Estimation in Nonlinear Mixed Effects Models with Stochastic DynamicsHelga Kristin Olafsdottir, Jacob Leander, Joachim Almquist, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2021
A stochastic mixed effects model to assess treatment effects and fluctuations in home-measured peak expiratory flow and the association with exacerbation risk in asthmaJacob Leander, Mats Jirstrand, Ulf G Eriksson, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 6, 2026
Modeling Peak Expiratory Flow in Patients With Asthma and Quantifying Treatment Effects Using a Mixed-Effects Hidden Markov ModelLudvig Jakobsson, Marcus Baaz, Jacob Leander, et al.
The AAPS Journal|February 20, 2015
Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker RatsJacob Leander, Joachim Almquist, Christine Ahlström, et al.
Statistics in Medicine|March 13, 2026
Location-Scale Latent Process Model for Repeated Ordinal Patient-Reported OutcomesAgnieszka Król, Robert Palmér, Jacob Leander, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 17, 2021
A semi-mechanistic exposure-response model to assess the effects of verinurad, a potent URAT1 inhibitor, on serum and urine uric acid in patients with hyperuricemia-associated diseasesJacob Leander, Mikael Sunnåker, Dinko Rekić, et al.
Pageof 2